Individual Investors Who Own 55% Along With Institutions Invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Saw Increase in Their Holdings Value Last Week

Yahoo FinanceNov 1 07:34 ET

Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday

BenzingaOct 25 14:09 ET

There's Reason For Concern Over Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Massive 61% Price Jump

Simply Wall StOct 25 08:59 ET

Shareholders Have Faith in Loss-making Sangamo Therapeutics (NASDAQ:SGMO) as Stock Climbs 55% in Past Week, Taking One-year Gain to 221%

Simply Wall StOct 24 08:29 ET

Truist Financial Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating

Moomoo NewsOct 24 06:39 ET · Ratings

TD Cowen Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating

Moomoo NewsOct 24 01:32 ET · Ratings